Insider: Baroldi Joseph EVP, Chief Business Officer - IONIS PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 41,317 | 4,347 | 45,664 |
| Value | $3,090,098.43 | $325,112.13 | $3,415,210.56 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 201 | Indirect | COM | $80.00 | $16,080.00 | 4,347 |
| 03/04/2026 | DDS | 238 | Indirect | COM | $80.00 | $19,040.00 | 4,347 |
| 03/03/2026 | DDS | 2,088 | Indirect | COM | $80.41 | $167,891.70 | 4,383 |
| 03/03/2026 | DDS | 4,096 | Direct | COM | $79.36 | $325,058.56 | 41,317 |
| 03/03/2026 | DDS | 36 | Indirect | COM | $81.01 | $2,916.36 | 4,347 |
| 01/30/2026 | DDS | 5,296 | Direct | COM | $82.96 | $439,364.10 | 45,413 |
| 01/16/2026 | DDS | 6,907 | Direct | COM | $75.75 | $523,205.25 | 40,431 |
| 01/16/2026 | DDS | 1,149 | Indirect | COM | $75.78 | $87,071.22 | 4,772 |
| 10/06/2025 | DDS | 1,625 | Direct | COM | $69.37 | $112,725.11 | 30,301 |
| 10/02/2025 | DDS | 15,000 | Direct | COM | $68.01 | $1,020,210.00 | 31,926 |
| 09/09/2025 | DDS | 11,950 | Direct | COM | $62.16 | $742,838.29 | 31,926 |
| 09/05/2025 | DDS | 250 | Direct | COM | $62.00 | $15,500.00 | 31,926 |
| 09/03/2025 | DDS | 2,800 | Direct | COM | $62.01 | $173,628.28 | 31,926 |
| 09/03/2025 | DDS | 30,000 | Direct | COM | $59.09 | $1,772,592.00 | 16,926 |
| 04/16/2025 | DDS | 3,928 | Direct | COM | $28.40 | $111,555.20 | 31,926 |
| 01/16/2025 | DDS | 3,401 | Direct | COM | $32.70 | $111,212.70 | 25,017 |
| 01/16/2025 | DDS | 1,029 | Indirect | COM | $32.70 | $33,648.30 | 3,071 |
| 04/16/2024 | DDS | 4,006 | Direct | COM | $41.60 | $166,640.79 | 19,631 |
| 01/17/2024 | DDS | 1,460 | Direct | COM | $50.42 | $73,608.82 | 12,799 |
| 01/17/2024 | DDS | 564 | Indirect | COM | $50.42 | $28,435.19 | 1,640 |
| 04/18/2023 | DDS | 3,880 | Direct | COM | $36.50 | $141,630.86 | 10,571 |
| 01/18/2023 | DDS | 375 | Indirect | COM | $39.79 | $14,920.05 | 851 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research